Open-label Study of Safety, Tolerability and Pharmacokinetics of Multiple Doses of BI-CON-02 in Patients With HER2-positive Metastatic Breast Cancer, Previously Treated With Trastuzumab
Clinical trial NCT03062007 · TERMINATED
Trial details
- NCT number
- NCT03062007
- Sponsor
- Biointegrator LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-06-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.